Avengers:Endgame box office collection: The superhero film earned Rs 31.5 crore on Monday, thus taking the total to Rs 189.7 crore.Avengers:Endgame box office collection: The superhero film earned Rs 31.5 crore on Monday, thus taking the total to Rs 189.7 crore.Marvel Cinematic Universe's latest film Avengers: Endgame is ready to overtake some of the biggest Bollywood blockbusters in India. The film may surpass Dangal, Tiger Zinda Hai and Sanju's box office collections by the end of its first week, reported film critc and trade ananlyst Taran Adarsh.
#AvengersEndgame is trending much, much better than #Hindi biggies... Will cross *Week 1* biz of #Dangal [ 197.54 cr], #TigerZindaHai [ 206.04 cr] and #Sanju [ 202.51 cr] on *Day 5*... All set to challenge *Week 1* biz of #Baahubali2 #Hindi [ 247 cr]. India biz.
taran adarsh (@taran_adarsh) April 30, 2019
The superhero film earned Rs 31.5 crore on Monday, thus taking the total to Rs 189.7 crore. The film is expected to have earned another Rs 30 crore on Tuesday, bringing its total collection to Rs 219 crore approximately. Released in India on April 26, the film has since then smashed several records at the ticket counter. Endgame has surpassed the opening weekend collections of its predecessor Avengers: Infinity War and Baahubali 2. While Infinity War had collected Rs 94.30 crore in its first weekend, Endgame, by contrast, collected Rs 157.20 crore, claimed Taran Adarsh.
#AvengersInfinityWar versus #AvengersEndgame... Opening Weekend biz...
taran adarsh (@taran_adarsh) April 29, 2019
2018: #AvengersInfinityWar 94.30 cr / 2000+ screens
2019: #AvengersEndgame 157.20 cr / 2845 screens
#AvengersEndgame has collected 66.70% higher numbers than #AvengersInfinityWar. Nett BOC. India biz.
Besides, Avengers: Endgame crossed the Rs 100 crore mark in just two days. India's biggest hit Baahubali 2 had taken three days to achieve the task.
#AvengersEndgame crosses cr in *2 days*... #Baahubali2 [#Hindi] crossed in *3 days* and so did the biggies from the *Hindi* film industry... #AvengersEndgame is all set to have the highest ever opening weekend... Boxoffice is on .
taran adarsh (@taran_adarsh) April 28, 2019
Released across 2,845 screens in India in Hindi, English, Tamil and Telugu, Endgame is the is the 22nd superhero film of the Marvel Studios. In Endgame, Marvel superheroes come to terms with their defeat in Infinity War and gear up against Thanos, the mega-villain of MCU. The film stars Robert Downey Jr. as Tony Stark aka Iron Man, Chris Hemsworth as Thor, Mark Ruffalo as Hulk, Chris Evans as Captain America, Scarlett Johansson as the Black Widow, Benedict Cumberbatch as Dr Strange, Don Cheadle as War Machine, Karen Gillan as Nebula, Josh Brolin as Thanos, Brie Larson as Captain Marvel and others.
Also read: Avengers: Endgame Box Office Collection Day 3: Marvel's superheroes film pacing towards Rs 200 crore
Worn tyres, unserviceable thrust reverser: DGCA flags critical lapses after audit at major airports
India holds ground as US trade deal hangs at 50-50 stage
Defence rally showing signs of froth; expert recommends short-term caution
Air India begins gradual resumption of international flights after Middle East airspace reopens
Timex Group Luxury Watches to sell 15% stake in India arm via OFS
109 Years In Mumbai, 35 In Delhi: Even Top Earners Struggle To Buy Homes In Indian Cities
Trump-Brokered Ceasefire Shattered: Iran Launches 6 Missile Waves, Israel Retaliates Deep Into Iran
Adani AGM: Gautam Adani On India’s Growth Amid Middle East Conflict And Global Economic Turmoil
Operation Sindoor | PM Modi: Indian Forces Crushed Enemies In 22 Minutes With Made-In-India Weapons
One-Month Cost For Weight Loss Drug At ₹17,345
Timex Group Luxury Watches to sell 15% stake in India arm via OFSDefence rally showing signs of froth; expert recommends short-term caution
Swiggy shares rebound 22% in a month; brokerages see further upside potential
Stock market today: Wild swing of 1,000 pts for Sensex, Nifty holds 25k; what's next?
HDB Financial IPO: How you can apply in 3 categories; check latest GMP, risk, views & more